Search results
Showing 721 to 735 of 9120 results
This quality standard covers the care of people with breast cancer after they have been referred to a specialist team. It includes the management of early (ductal carcinoma in situ and invasive), locally advanced and advanced breast cancer; recurrent breast cancer; and familial breast cancer. It describes high-quality care in priority areas for improvement.
View quality statements for QS12Show all sections
Sections for QS12
- Quality statements
- Quality statement 1: Timely diagnosis
- Quality statement 2: Preoperative MRI scan
- Quality statement 3: Tumour profiling tests
- Quality statement 4: ER and HER2 receptor status
- Quality statement 5: Multidisciplinary team management of metastatic breast cancer
- Quality statement 6: Key worker
- Update information
This webpage covers NICE guidelines on breast cancer. The table below presents the guidelines alphabetically with links to the surveillance report...
This quality standard covers the diagnosis and initial management of ectopic pregnancy and miscarriage in women, trans men and non-binary people in their first trimester (up to 13 completed weeks of pregnancy). It includes assessment and diagnosis for people with suspected early pregnancy loss. It describes high-quality care in priority areas for improvement.
View quality statements for QS69Show all sections
Sections for QS69
- Quality statements
- Quality statement 1: Timely referral to early pregnancy assessment services
- Quality statement 2: Ultrasound to identify miscarriage or tubal ectopic pregnancy
- Quality statement 3: Confirming a diagnosis of miscarriage
- Quality statement 4: Anti-D immunoglobulin prophylaxis (up to and including 11+6 weeks of pregnancy)
- Update information
- About this quality standard
All NICE products on infectious disease prevention and control. Includes any guidance, advice and quality standards.
All NICE products on artificial intelligence. Includes any guidance and advice.
All NICE products on complications of cancer. Includes any guidance, advice and quality standards.
All NICE products on eating disorders. Includes any guidance and quality standards.
This webpage covers all NICE's guidelines on cardiometabolic disease prevention and treatment The table presents the guidelines alphabetically within...
This quality standard covers care after emergency treatment for suspected anaphylaxis, including assessment and referral to specialist allergy services. It describes high-quality care in priority areas for improvement.
View quality statements for QS119Show all sections
Sections for QS119
- Quality statements
- Quality statement 1: Initial education in adrenaline auto-injector use
- Quality statement 2: Referral to specialist allergy services after emergency treatment
- Quality statement 3: Specialist assessment for venom immunotherapy
- Quality statement 4: Ongoing training in adrenaline auto-injector use
- Update information
- About this quality standard
This quality standard covers diagnosing and managing drug allergy in adults, young people and children. It describes high-quality care in priority areas for improvement.
View quality statements for QS97Show all sections
Sections for QS97
- Quality statements
- Quality statement 1: Documentation using the structured assessment guide
- Quality statement 2: Advice about carrying personal structured drug information
- Quality statement 3: Referral to specialist drug allergy services
- Quality statement 4: Recording drug allergy status in electronic medical records
- Quality statement 5: Updating information on drug allergy status
- Quality statement 6 (developmental): Prescription information on drug avoidance
- Update information
All NICE products on cerebral palsy. Includes any guidance, advice and quality standards.
All NICE products on service transition. Includes any guidance and quality standards.
This quality standard covers diagnostic reporting and the organisation of haematological cancer services for people of all ages (children, adults and young people) and managing haematological cancers in adults and young people (aged 16 and over). It describes high-quality care in priority areas for improvement.
View quality statements for QS150Show all sections
Sections for QS150
All NICE products on peritoneal cancer. Includes any guidance.
All NICE products on prostate cancer. Includes any guidance, advice and quality standards.